NASDAQ:OKUR | Free Cash Flow | OnKure Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$12.94M$5,000.00-$12.94M
2025-12-31-$11.51M$9,000.00-$11.52M
2025-03-31-$14.01M$18,000.00-$14.02M
2024-12-31-$23.35M$15,000.00-$23.37M
2024-03-31-$10.63M$9,000.00-$10.64M
2023-12-31$9.38M$50,000.00$9.33M50.39%
2023-03-31-$9.05M$172,000.00-$9.22M
2022-12-31-$15.61M$250,000.00-$15.86M
2022-03-31-$9M$44,000.00-$9.04M
2021-12-31-$10.02M$90,000.00-$10.11M
2021-03-31-$8.59M$25,000.00-$8.61M
2020-12-31-$5.41M$16,000.00-$5.43M
2020-03-31-$4.45M$1,000.00-$4.45M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$51.83M$46,000.00-$51.87M
2024-12-31-$51.12M$52,000.00-$51.17M
2023-12-31-$34.55M$246,000.00-$34.79M
2022-12-31-$47.36M$346,000.00-$47.71M
2021-12-31-$37.98M$198,000.00-$38.18M
2020-12-31-$18.54M$24,000.00-$18.56M